Clinical Trials for Solid Tumours

Find clinical trials for solid tumours. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT ID: NCT06789172

This clinical trial is testing a new drug called OKN4395, both on its own and together with another medication called pembrolizumab, in patients with different types of solid tumors like sarcoma an...

Recruiting

Phase: PHASE1 Type: interventional Locations: Santa Monica, California, United States, Oxford, , United Kingdom +6 more

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

NCT ID: NCT06619509

This clinical trial is looking at how well adults with solid tumors can handle long-term treatment with a medication called brigimadlin. This study is specifically for individuals who have already ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Madison, Wisconsin, United States +68 more

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

NCT ID: NCT04529122

The WAYFIND-R trial is designed to gather important information about cancer patients with solid tumors. This study will collect data on how next-generation sequencing (a modern testing method that...

Recruiting

Type: observational Locations: Lyon, , France, Zaragoza, , Spain +218 more

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

NCT ID: NCT06581432

The Beamion PANTUMOR-1 clinical trial is studying a new medication called zongertinib to see if it helps people with advanced cancers that have changes in a gene called HER2. These changes can make...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States, New York, New York, United States +111 more

A Study to Evaluate the Safety and Tolerability of EP0089

NCT ID: NCT07030478

This clinical trial is studying a new treatment called EP0089 for adults with advanced solid tumors—these are cancers that form solid lumps in the body. The goal of this early-phase study is to fin...

Not yet recruiting

Phase: PHASE1 Type: interventional

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT ID: NCT05770102

The DETERMINE Trial Treatment Arm 02 is studying a drug called atezolizumab, which is already used to treat certain types of cancer in adults. This trial aims to see if atezolizumab can help patien...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Leeds, , United Kingdom +26 more

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

NCT ID: NCT06815575

This clinical trial is evaluating a new treatment called RC220, both on its own and combined with a standard chemotherapy drug called doxorubicin, for adults with advanced solid tumors. The study a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Gosford, New South Wales, Australia, Miranda, New South Wales, Australia +2 more

Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study

NCT ID: NCT06589414

This clinical trial is looking at how helpful it can be for cancer patients to have a follow-up meeting with their general practitioner (GP) after they receive their cancer diagnosis. The goal is t...

Recruiting

Phase: NA Type: interventional Locations: Auch, , France, Toulouse, , France +2 more

Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours

NCT ID: NCT06725758

This clinical trial is studying a new treatment called ODM-212 for patients with certain advanced solid tumors, which are types of cancer that form solid masses, like lung cancer or mesothelioma. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, , United Kingdom

Tissue Collection Framework To Improve Outcomes In Solid Tumours

NCT ID: NCT03572192

This clinical trial, titled "Tissue Collection Framework To Improve Outcomes In Solid Tumours," is focused on understanding why some cancers spread and become resistant to treatments. Researchers w...

Recruiting

Type: observational Locations: London, , United Kingdom

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions